Terms: = Colorectal cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
146 results:
1. Targeted inhibition of colorectal cancer proliferation: The dual-modulatory role of 2,4-DTBP on anti-apoptotic Bcl-2 and Survivin proteins.
Saha P; Hegde M; Chakraborty K; Singha A; Mukerjee N; Ghosh D; Kunnumakkara AB; Khan MS; Ahmad MI; Ghosh A; Kumer A; Sil SK
J Cell Mol Med; 2024 Apr; 28(7):e18150. PubMed ID: 38494866
[TBL] [Abstract] [Full Text] [Related]
2. Modes of Interactions with DNA/HSA Biomolecules and Comparative Cytotoxic Studies of Newly Synthesized Mononuclear Zinc(II) and Heteronuclear Platinum(II)/Zinc(II) Complexes toward colorectal cancer Cells.
Vučelj S; Hasić R; Ašanin D; Šmit B; Caković A; Bogojeski J; Serafinović MĆ; Marković BS; Stojanović B; Pavlović S; Stanisavljević I; Ćorović I; Stojanović MD; Jovanović I; Soldatović TV; Stojanović B
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474273
[TBL] [Abstract] [Full Text] [Related]
3. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis.
Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
[TBL] [Abstract] [Full Text] [Related]
4. Berberine and RNAi-Targeting Telomerase Reverse Transcriptase (tert) and/or Telomerase RNA Component (TERC) Caused Oxidation in colorectal cancer Cell Line, HCT 116: An Integrative Approach using Molecular and Metabolomic Studies.
Samad MA; Saiman MZ; Abdul Majid N; Karsani SA; Yaacob JS
Cell Biochem Biophys; 2024 Mar; 82(1):153-173. PubMed ID: 38198024
[TBL] [Abstract] [Full Text] [Related]
5.
Jung EJ; Kim HJ; Shin SC; Kim GS; Jung JM; Hong SC; Kim CW; Lee WS
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139333
[TBL] [Abstract] [Full Text] [Related]
6. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
[TBL] [Abstract] [Full Text] [Related]
7. MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer.
Liu W; Chen S; Xie W; Wang Q; Luo Q; Huang M; Gu M; Lan P; Chen D
Cell Mol Biol Lett; 2023 Oct; 28(1):80. PubMed ID: 37828426
[TBL] [Abstract] [Full Text] [Related]
8. First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial.
Thibaudin M; Fumet JD; Chibaudel B; Bennouna J; Borg C; Martin-Babau J; Cohen R; Fonck M; Taieb J; Limagne E; Blanc J; Ballot E; Hampe L; Bon M; Daumoine S; Peroz M; Mananet H; Derangère V; Boidot R; Michaud HA; Laheurte C; Adotevi O; Bertaut A; Truntzer C; Ghiringhelli F
Nat Med; 2023 Aug; 29(8):2087-2098. PubMed ID: 37563240
[TBL] [Abstract] [Full Text] [Related]
9. PREVALENCE OF SERRATED POLYPS AND THEIR ASSOCIATION WITH SYNCHRONOUS colorectal ADVANCED ADENOMAS.
Meine GC; Sander GB
Arq Gastroenterol; 2023; 60(2):224-229. PubMed ID: 37556749
[TBL] [Abstract] [Full Text] [Related]
10. Phthalocyanine-Blue Nanoparticles for the Direct Visualization of Tumors with White Light Illumination.
Amirshaghaghi A; Chang WC; Chhay B; Bartolomeu AR; Clapper ML; Cheng Z; Tsourkas A
ACS Appl Mater Interfaces; 2023 Jul; 15(28):33373-33381. PubMed ID: 37395349
[TBL] [Abstract] [Full Text] [Related]
11. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
[TBL] [Abstract] [Full Text] [Related]
12. Cribriform Morular Thyroid Carcinoma - Ultimobranchial Pouch-Related? Deep Molecular Insights of a Unique Case.
Dettmer MS; Hürlimann S; Scheuble L; Vassella E; Perren A; Wicke C
Endocr Pathol; 2023 Sep; 34(3):342-348. PubMed ID: 37249797
[TBL] [Abstract] [Full Text] [Related]
13. Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
Braun S; Paskaš S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
ChemMedChem; 2023 Jul; 18(14):e202300206. PubMed ID: 37160667
[TBL] [Abstract] [Full Text] [Related]
14. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
[TBL] [Abstract] [Full Text] [Related]
15. Synthesis of Nonsymmetrically Substituted 2,3-Dialkoxyphenazine Derivatives and Preliminary Examination of Their Cytotoxicity.
Ręka P; Grolik J; Stadnicka KM; Kołton-Wróż M; Wołkow P
J Org Chem; 2023 Feb; 88(3):1339-1351. PubMed ID: 36639775
[TBL] [Abstract] [Full Text] [Related]
16. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
Li K; Liu Y; Han J; Gui J; Zhang X
Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
[TBL] [Abstract] [Full Text] [Related]
17. A pilot study investigating the role of
Smith D; Joon DL; Knight K; Sim J; Schneider M; Lau E; Foroudi F; Khoo V
J Med Radiat Sci; 2022 Dec; 69(4):439-447. PubMed ID: 35906833
[TBL] [Abstract] [Full Text] [Related]
18. Identification of mechanism of cancer-cell-specific reactivation of htert offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer.
Akıncılar SC; Chua JYH; Ng QF; Chan CHT; Eslami-S Z; Chen K; Low JL; Arumugam S; Aswad L; Chua C; Tan IB; DasGupta R; Fullwood MJ; Tergaonkar V
Nucleic Acids Res; 2023 Jan; 51(1):1-16. PubMed ID: 35697349
[TBL] [Abstract] [Full Text] [Related]
19. Bioengineered Protein Nanocage by Small Heat Shock Proteins Delivering mtert siRNA for Enhanced colorectal cancer Suppression.
Wang H; Liu N; Yang F; Hu N; Wang M; Cui M; Bruns N; Guan X
ACS Appl Bio Mater; 2022 Mar; 5(3):1330-1340. PubMed ID: 35234441
[TBL] [Abstract] [Full Text] [Related]
20. Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer.
Elsayed I; Elsayed N; Feng Q; Sheahan K; Moran B; Wang X
Cancer Biomark; 2022; 33(2):261-271. PubMed ID: 35213358
[TBL] [Abstract] [Full Text] [Related]
[Next]
